• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.

作者信息

Müller R, Lebrach F

出版信息

Pharmatherapeutica. 1980;2(6):372-9.

PMID:7001492
Abstract

The pathophysiology of disturbances in platelet function and intravasal hypercoagulability in diseases with impaired microcirculation is reviewed, and related relevant experimental and clinical findings with pentoxifylline are presented. Recent studies have revealed the antithrombotic properties of pentoxifylline which contribute to its haemorheological profile and therapeutical efficacy.

摘要

相似文献

1
Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.
Pharmatherapeutica. 1980;2(6):372-9.
2
Pentoxifylline -- a biomedical profile.
J Med. 1979;10(5):307-29.
3
The haemorheological and antithrombotic potential of pentoxifylline ('Trental'): a review.己酮可可碱（“曲克芦丁”）的血液流变学及抗血栓形成潜能：综述
Pharmatherapeutica. 1988;5(3):159-69.
4
Hemorheology and peripheral vascular diseases: a new therapeutic approach.血液流变学与周围血管疾病：一种新的治疗方法。
J Med. 1981;12(4):209-35.
5
[Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].[缺血性血管病中的血液凝固、纤维蛋白溶解和流变学参数。己酮可可碱在急性脑血管病治疗中的作用]
Ric Clin Lab. 1981;11 Suppl 1:353-71.
6
Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.
J Med. 1979;10(5):347-64.
7
[Hemorheological, hemocoagulation and photoplethysmographic changes induced by the administration of pentoxifylline in patients with Raynaud's disease].[己酮可可碱对雷诺病患者血液流变学、凝血及光电容积脉搏波的影响]
Minerva Med. 1985 Jul 31;76(30-31):1401-5.
8
[Clinical pharmacology and pharmacokinetics of pentoxifylline].己酮可可碱的临床药理学与药代动力学
Ric Clin Lab. 1988;18 Suppl 2:3-33.
9
[Pentoxifylline in the blood rheological and coagulative changes in chronic respiratory failure].[己酮可可碱对慢性呼吸衰竭血液流变学及凝血变化的影响]
Arch Monaldi Mal Torace. 1990 Jan-Feb;45(1):31-8.
10
Antithrombotic potential of pentoxifylline. A hemorheologically active drug.
Angiology. 1985 Jun;36(6):387-98. doi: 10.1177/000331978503600608.

引用本文的文献

1
Pentoxifylline for the prevention of contrast-induced nephropathy in diabetic patients undergoing angioplasty: a randomized controlled trial.己酮可可碱预防经皮腔内血管成形术的糖尿病患者对比剂肾病：一项随机对照试验。
Int Urol Nephrol. 2019 Apr;51(4):699-705. doi: 10.1007/s11255-019-02104-6. Epub 2019 Mar 4.
2
Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.己酮可可碱治疗心血管疾病的潜在疗效。
Exp Clin Cardiol. 2004 Summer;9(2):103-11.
3
Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study.
己酮可可碱、白蛋白排泄率与 I 型和 II 型糖尿病微量蛋白尿患者的蛋白尿。一项短期随机研究的结果
Acta Diabetol Lat. 1986 Apr-Jun;23(2):171-7. doi: 10.1007/BF02624677.
4
Pentoxifylline, total urinary protein excretion rate and arterial blood pressure in long-term insulin-dependent diabetic patients with overt nephropathy.己酮可可碱、长期胰岛素依赖型显性肾病糖尿病患者的尿蛋白排泄率及动脉血压
Acta Diabetol Lat. 1987 Jul-Sep;24(3):229-39. doi: 10.1007/BF02732042.
5
Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.己酮可可碱。对其药效学和药代动力学特性以及治疗效果的综述。
Drugs. 1987 Jul;34(1):50-97. doi: 10.2165/00003495-198734010-00003.
6
Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.丁咯地尔。对其药效学和药代动力学特性以及在周围血管疾病和脑血管疾病中的治疗效果的综述。
Drugs. 1987 May;33(5):430-60. doi: 10.2165/00003495-198733050-00002.